Trademark Attorney / Law Firm
James DeYonker – Trademark Portfolio
James DeYonker has 29 trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 14 trademarks are successfully registered — a 48% registration rate. The strongest areas of practice include Class 31 (Natural Agricultural Products) and Class 5 (Pharmaceuticals). Filing activity has been recorded from 2015 through 2025, spanning 5 years.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
James DeYonker's trademark practice covers 6 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademark applications has James DeYonker filed?
James DeYonker has filed 29 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 14 registered, 15 abandoned.
What trademark classes does James DeYonker specialize in?
James DeYonker has filed trademarks across 6 Nice Classification classes. The most common practice areas include Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 20 (Furniture), Class 21 (Housewares), Class 10 (Medical Apparatus). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
How long has James DeYonker been filing trademarks?
James DeYonker's trademark filing history with the USPTO spans from 2015 to 2025, covering 10 years of trademark practice. During this period, James DeYonker has handled 29 trademark applications.
What is James DeYonker's trademark registration success rate?
James DeYonker has a 48% trademark registration rate, with 14 out of 29 resolved applications resulting in successful registration. Currently, 0 applications are pending review.